In cardiometabolic care, tools such as ambulatory blood pressure monitoring ABPM and 24 hr blood pressure monitors continue to play a key role in detecting masked hypertension and supporting risk evaluation. Still, traditional ABPM devices often provide only a limited view of ongoing patient trends.
Biobeat’s FDA cleared blood pressure monitor introduces a different approach through a lightweight, non invasive wearable patch that enables continuous blood pressure monitoring.
This cuffless blood pressure monitor operates as a continuous BP monitor, delivering accurate, real time data without disrupting daily activities. By advancing cuffless monitoring technology, clinicians can move toward more consistent, data driven care across cardiometabolic populations.
We will be sharing how our FDA cleared, medical grade, validated cuffless blood pressure monitoring platform is enhancing hypertension diagnosis and management, improving both patient experience and clinical outcomes.
Join the discussion on how ambulatory BP monitoring is shifting toward more continuous, connected solutions in cardiometabolic care.